glutathione s transferase alverine RCSB PDB Glutathione S-transferase | Glutathione transferases;

Hu T, Schreiter FC, Bagchi RA, Tatman PD, Hannink M, McKinsey TA

The Glutathione industry is valued at US$ 324.6 million in 2025, and is estimated to hit the US$ 585.8 million mark by the year 2032, reflecting an annual growth rate of 8.8%

The benefits of maintaining healthy levels are numerous, including acute or chronic illnesses such as: Alzheimers disease Cancer Chronic fatigue syndrome Cystic fibrosis Multiple sclerosis Repeated exposure to toxins & heavy metals Inflammatory diseases such as arthritis Cardiovascular disease COPD, asthma, or any chronic breathing problems Chronic stress Anxiety Aging Neurological diseases Viral hepatitis or Cirrhosis Autism

301, G32G38